# Ocama Partners

Ocama Partners is a Single Family Office based in San Juan, Puerto Rico.

## Overview

- **Organization type:** Single Family Office
- **Headquarters:** San Juan, Puerto Rico
- **Region:** North America
- **Address:** San Juan, Puerto Rico
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** ocamapartners.com
- **LinkedIn:** https://www.linkedin.com/company/ocama-partners

## Regulatory record

- **Reports private funds:** No

## About

Ocama Partners functions as a single-family office headquartered in San Juan, Puerto Rico. No public record discloses the founding year or the specific family branch behind the capital. The firm maintains a private investment vehicle structure centered on mental health advancements. The office targets Cannabis & Psychedelics, Digital Health, and Healthcare Services. It executes via direct co-investments and SPVs rather than broad fund commitments. Confirmed positions include Delix Therapeutics (Series A, 2021) and Sensorium Therapeutics (Series A, 2022). All activity remains within North America. Team details stay limited. Lourenço Bustani appears as Principal and Kevin as Partner. No additional offices, headcount, or adjacent vehicles appear in public materials. No operational event from the last 24 months is recorded. The structure centers on a narrow mandate that aligns family capital with psychedelic and biotech research vehicles. This produces repeated co-investor ties to specialist funds rather than broad LP commitments.

## Sectors

- Cannabis & Psychedelics
- Digital Health
- Healthcare Services
- AI/ML
- Biotech

## People

- Lourenço Bustani — Principal
- Kevin — Partner

## Questions

### Who runs investment decisions at Ocama Partners?

Lourenço Bustani serves as Principal. Kevin is listed as Partner. No additional decision-makers appear in public records.

### Does Ocama Partners participate in fund commitments or only direct deals?

The firm executes through direct co-investments and SPVs. It joined Series A rounds for Delix Therapeutics in 2021 and Sensorium Therapeutics in 2022 alongside other venture investors.

### What investment stages does Ocama Partners typically target?

Seed through Series B. Confirmed activity centers on Series A financings in biotech and psychedelics.

### Which sectors does Ocama Partners focus on?

Cannabis & Psychedelics, Digital Health, and Healthcare Services. Technology emphasis includes AI/ML and Biotech.

### Where does Ocama Partners invest geographically?

All disclosed activity occurs in North America.

## Related profiles

- [Obsido](https://altss.com/profile/obsido)
- [O Capital Group](https://altss.com/profile/o-capital-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ocama-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology